{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:19:21Z","timestamp":1792981161271,"version":"4.5.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Spinal Cord Injury (SCI) is a severe central nervous system disorder that initiates inflammatory reactions, exacerbating tissue damage and impeding neuronal repair. Macrophage polarization plays a critical role in this pathological process: it significantly regulates inflammation resolution and tissue regeneration, rendering its modulation a key strategy for SCI repair. Omaveloxolone (Omav), a novel Nrf2 activator, has demonstrated potential in regulating inflammatory responses, suggesting it may serve as a promising candidate for SCI intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To evaluate the efficacy and underlying mechanism of Omav in SCI repair, a spinal cord contusion model was established in animal subjects. Additionally, an\n                      <jats:italic>in vitro<\/jats:italic>\n                      lipopolysaccharide (LPS)-induced macrophage polarization model was constructed to further validate Omav\u2019s effects on macrophage phenotypes. RNA sequencing (RNA-seq) was employed to elucidate the molecular pathways through which Omav modulates post-SCI pathophysiology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vivo<\/jats:italic>\n                      experiments revealed that Omav effectively restored motor function in SCI-induced animals. RNA-seq analysis further demonstrated that Omav reshaped inflammatory cascades following SCI, with a significant impact on macrophage polarization dynamics. Specifically, Omav promoted the formation of an M2-dominant macrophage landscape (a phenotype associated with anti-inflammation and tissue repair) while reducing the pro-inflammatory M1 macrophage phenotype. These findings were corroborated by in vitro studies, which confirmed that Omav directly facilitated M2-type macrophage polarization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results collectively confirm the efficacy of Omav in repairing spinal cord injury by targeting macrophage polarization and regulating inflammatory responses. This study not only highlights the therapeutic potential of Omav for SCI but also provides a novel pharmacological strategy for SCI treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnmol.2025.1737798","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:19:51Z","timestamp":1768205991000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Omaveloxolone promotes functional recovery of spinal cord injury by reducing inflammatory response and regulating macrophage polarization"],"prefix":"10.3389","volume":"18","author":[{"given":"Pengtian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erke","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunxu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyou","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1017\/s1462399409001288","article-title":"Extrinsic and intrinsic factors controlling axonal regeneration after spinal cord injury","volume":"11","author":"Afshari","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"17018","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.3390\/ijms21207533","article-title":"Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms","volume":"21","author":"Anjum","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2018.9.Spine18682","article-title":"Time is spine: a review of translational advances in spinal cord injury","volume":"30","author":"Badhiwala","year":"2019","journal-title":"J. Neurosurg. Spine"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1517\/13543780902897623","article-title":"Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury","volume":"18","author":"Baptiste","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/neu.2006.23.635","article-title":"Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains","volume":"23","author":"Basso","year":"2006","journal-title":"J. Neurotrauma"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.nec.2016.08.004","article-title":"Restorative treatments for spinal cord injury","volume":"28","author":"Chen","year":"2017","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41591-019-0475-6","article-title":"Spinal cord repair: advances in biology and technology","volume":"25","author":"Courtine","year":"2019","journal-title":"Nat. Med."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.2147\/ott.S136992","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors","volume":"10","author":"Creelan","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12974-020-01973-4","article-title":"Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages\/microglia polarization and affords neuroprotection after spinal cord injury","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1014013","DOI":"10.3389\/fimmu.2022.1014013","article-title":"Advances in the research of the role of macrophage\/microglia polarization-mediated inflammatory response in spinal cord injury","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.01.064","article-title":"Carboxyl- and amino-functionalized polystyrene nanoparticles differentially affect the polarization profile of M1 and M2 macrophage subsets","volume":"85","author":"Fuchs","year":"2016","journal-title":"Biomaterials"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.actbio.2021.03.018","article-title":"Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy","volume":"126","author":"Gao","year":"2021","journal-title":"Acta Biomater."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000338297","article-title":"Spinal cord injury and traumatic brain injury: a cost-of-illness study","volume":"39","author":"Garc\u00eda-Alt\u00e9s","year":"2012","journal-title":"Neuroepidemiology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1517\/14728222.2011.553605","article-title":"Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages","volume":"15","author":"Gensel","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2014.12.045","article-title":"Macrophage activation and its role in repair and pathology after spinal cord injury","volume":"1619","author":"Gensel","year":"2015","journal-title":"Brain Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-physiol-022516-034348","article-title":"Macrophages and the recovery from acute and chronic inflammation","volume":"79","author":"Hamidzadeh","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1007\/s12035-023-03814-w","article-title":"Targeted therapy of spinal cord injury: inhibition of apoptosis is a promising therapeutic strategy","volume":"61","author":"He","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/cphy.c130045","article-title":"Autonomic consequences of spinal cord injury","volume":"4","author":"Hou","year":"2014","journal-title":"Compr. Physiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.bioactmat.2024.05.015","article-title":"ROS-responsive nanoparticle delivery of ferroptosis inhibitor prodrug to facilitate mesenchymal stem cell-mediated spinal cord injury repair","volume":"38","author":"Hua","year":"2024","journal-title":"Bioact Mater."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"109067","DOI":"10.1016\/j.intimp.2022.109067","article-title":"Omaveloxolone attenuates the sepsis-induced cardiomyopathy via activating the nuclear factor erythroid 2-related factor 2","volume":"111","author":"Jian","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"952950","DOI":"10.3389\/fphar.2022.952950","article-title":"Omaveloxolone inhibits IL-1\u03b2-induced chondrocyte apoptosis through the Nrf2\/ARE and NF-\u03baB signalling pathways in vitro and attenuates osteoarthritis in vivo","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1111\/cns.14222","article-title":"Zinc defends against Parthanatos and promotes functional recovery after spinal cord injury through SIRT3-mediated anti-oxidative stress and mitophagy","volume":"29","author":"Jiang","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1523\/jneurosci.3257-09.2009","article-title":"Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord","volume":"29","author":"Kigerl","year":"2009","journal-title":"J. Neurosci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.neuron.2014.07.027","article-title":"TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord","volume":"83","author":"Kroner","year":"2014","journal-title":"Neuron"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.spinee.2003.07.007","article-title":"Pathophysiology and pharmacologic treatment of acute spinal cord injury","volume":"4","author":"Kwon","year":"2004","journal-title":"Spine J."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40265-023-01874-9","article-title":"Omaveloxolone: first approval","volume":"83","author":"Lee","year":"2023","journal-title":"Drugs"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"112188","DOI":"10.1016\/j.intimp.2024.112188","article-title":"Recombinant fibroblast growth factor 4 ameliorates axonal regeneration and functional recovery in acute spinal cord injury through altering microglia\/macrophage phenotype","volume":"134","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"14503","DOI":"10.1021\/acsami.3c13984","article-title":"Modified ZIF-8 nanoparticles for targeted metabolic treatment of acute spinal cord injury","volume":"16","author":"Lin","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"115043","DOI":"10.1016\/j.expneurol.2024.115043","article-title":"MAPK signaling pathway in spinal cord injury: mechanisms and therapeutic potential","volume":"383","author":"Lin","year":"2025","journal-title":"Exp. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.redox.2015.12.005","article-title":"The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation","volume":"8","author":"Liu","year":"2016","journal-title":"Redox Biol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbi.2014.11.007","article-title":"Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury","volume":"45","author":"Ma","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ca.22432","article-title":"The microanatomy of spinal cord injury: a review","volume":"28","author":"Mortazavi","year":"2015","journal-title":"Clin. Anat."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"122873","DOI":"10.1016\/j.biomaterials.2024.122873","article-title":"LDH nanoparticles-doped cellulose nanofiber scaffolds with aligned microchannels direct high-efficiency neural regeneration and organized neural circuit remodeling through RhoA\/Rock\/Myosin II pathway","volume":"314","author":"Pang","year":"2025","journal-title":"Biomaterials"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2471\/blt.06.030973","article-title":"Assessing the burden of injury in six European countries","volume":"85","author":"Polinder","year":"2007","journal-title":"Bull. World Health Organ."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10143-018-1008-3","article-title":"Recent update on basic mechanisms of spinal cord injury","volume":"43","author":"Quadri","year":"2020","journal-title":"Neurosurg. Rev."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.bioactmat.2022.07.002","article-title":"Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury","volume":"25","author":"Ran","year":"2023","journal-title":"Bioact Mater."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e22526","DOI":"10.1002\/jbt.22526","article-title":"Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis","volume":"34","author":"Reisman","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/dddt.S193889","article-title":"Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates","volume":"13","author":"Reisman","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e0206464","DOI":"10.1371\/journal.pone.0206464","article-title":"Training with brain-machine interfaces, visuo-tactile feedback and assisted locomotion improves sensorimotor, visceral, and psychological signs in chronic paraplegic patients","volume":"13","author":"Shokur","year":"2018","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.conb.2016.12.005","article-title":"Spatial and temporal arrangement of neuronal intrinsic and extrinsic mechanisms controlling axon regeneration","volume":"42","author":"Tedeschi","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1179\/2045772314y.0000000233","article-title":"The changing demographics of traumatic spinal cord injury: an 11-year study of 831 patients","volume":"38","author":"Thompson","year":"2015","journal-title":"J. Spinal Cord Med."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/1673-5374.375304","article-title":"Pharmacological interventions targeting the microcirculation following traumatic spinal cord injury","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"E1066","DOI":"10.1097\/brs.0000000000003503","article-title":"Butylphthalide has an anti-inflammatory role in spinal cord injury by promoting macrophage\/microglia M2 polarization via p38 phosphorylation","volume":"45","author":"Wang","year":"2020","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112826","article-title":"RTA 408 inhibits interleukin-1\u03b2-induced MMP-9 expression via suppressing protein kinase-dependent NF-\u03baB and AP-1 activation in rat brain astrocytes","volume":"20","author":"Yang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-020-01805-5","article-title":"LncGBP9\/miR-34a axis drives macrophages toward a phenotype conducive for spinal cord injury repair via STAT1\/STAT6 and SOCS3","volume":"17","author":"Zhou","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"22928","DOI":"10.1021\/acsnano.3c08046","article-title":"Schwann cell-derived exosomes and methylprednisolone composite patch for spinal cord injury repair","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2025.1737798\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:19:53Z","timestamp":1768205993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2025.1737798\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":48,"alternative-id":["10.3389\/fnmol.2025.1737798"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2025.1737798","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1737798"}}